Efficient Drug Development

TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Do you want to exchange knowledge?

Steven Erpelinck is happy to talk to you.

Contact me

Our latest developments

15 resultaten, getoond 1 t/m 5

From lab to life in 24 Hours: i-screen demonstrates correlation between laboratory and human gut responses

Informatietype:
Insight
10 February 2026
In a 12-week human study, TNO showed that 24-hour i-screen microbiome changes predicted responses at 8 and 12 weeks, supporting confident decisions before costly trials.
Read more
over From lab to life in 24 Hours: i-screen demonstrates correlation between laboratory and human gut responses

Testing medicines outside the body: intestinal–liver–kidney model accelerates drug development

Informatietype:
Insight
29 July 2025
Read more
over Testing medicines outside the body: intestinal–liver–kidney model accelerates drug development

Preclinical ADME

Informatietype:
Article
Read more
over Preclinical ADME

TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

Informatietype:
News
25 March 2024
Read more
over TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

PPP uncovers new insights into MASLD development

Informatietype:
Insight
15 February 2024
Read more
over PPP uncovers new insights into MASLD development